Human CD33 Deficiency

被引：0
|
作者：
Geier, C. B. [1 ]
Bra, D. [1 ]
Linder, A. [1 ]
Eibl, M. M. [1 ]
Wolf, H. M. [1 ]
机构：
[1] Immunol Tagesklin, Vienna, Austria
来源：
JOURNAL OF CLINICAL IMMUNOLOGY | 2014年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
ESID-0272
引用
收藏
页码：S209 / S209
页数：1
相关论文
共 50 条
  • [31] EXPRESSION OF CD33 ANTIGEN ON NORMAL HUMAN ACTIVATED T-LYMPHOCYTES
    NAKAMURA, Y
    NOMA, M
    KIDOKORO, M
    KOBAYASHI, N
    TAKEI, M
    KURASHIMA, S
    MUKAIYAMA, T
    KATO, S
    BLOOD, 1994, 83 (05) : 1442 - 1443
  • [32] Relationship between CD33 expression, splicing polymorphism, and in vitro cytotoxicity of gemtuzumab ozogamicin and the CD33/CD3 BiTE® AMG 330
    Laszlo, George S.
    Beddoe, Mary E.
    Godwin, Colin D.
    Bates, Olivia M.
    Gudgeon, Chelsea J.
    Harrington, Kimberly H.
    Walter, Roland B.
    HAEMATOLOGICA, 2019, 104 (02) : E59 - E62
  • [33] Evaluation Of CD33 Expression and Functional Analysis Of The CD33/CD3 Bispecific BiTE® Antibody AMG 330 In Primary AML Samples
    Krupka, Christina
    Kufer, Peter
    Kischel, Roman
    Zugmaier, Gerhard
    Boegeholz, Jan
    Koehnke, Thomas
    Lichtenegger, Felix S.
    Schneider, Stephanie
    Metzeler, Klaus H.
    Fiegl, Michael
    Spiekermann, Karsten
    Baeuerle, Patrick
    Hiddemann, Wolfgang
    Riethmueller, Gert
    Subklewe, Marion
    BLOOD, 2013, 122 (21)
  • [34] IL-6-induced activation of MYC is responsible for the down-regulation of CD33 expression in CD33(+) myeloma cells
    Karim Shamsasenjan
    Ken-ichiro Otsuyama
    Saeid Abroun
    Mohd S. Iqbal
    Maged S. Mahmoud
    Hideki Asaoku
    Michio M. Kawano
    International Journal of Hematology, 2009, 89 : 310 - 318
  • [35] IL-6-induced activation of MYC is responsible for the down-regulation of CD33 expression in CD33(+) myeloma cells
    Shamsasenjan, Karim
    Otsuyama, Ken-ichiro
    Abroun, Saeid
    Iqbal, Mohd S.
    Mahmoud, Maged S.
    Asaoku, Hideki
    Kawano, Michio M.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 89 (03) : 310 - 318
  • [36] Phagocytic function is reinforced by deletion of CD33 in human THP1 macrophages
    Nozaki, I.
    Neumann, H.
    Mathews, M.
    Kopatz, J.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 768 - 769
  • [37] Expression and functional characterization of CD33 transcript variants in human acute myeloid leukemia
    Laszlo, George S.
    Harrington, Kimberly H.
    Gudgeon, Chelsea J.
    Beddoe, Mary E.
    Fitzgibbon, Matthew P.
    Ries, Rhonda E.
    Lamba, Jatinder K.
    McIntosh, Martin W.
    Meshinchi, Soheil
    Walter, Roland B.
    ONCOTARGET, 2016, 7 (28) : 43281 - 43294
  • [38] Targeting CD33 for acute myeloid leukemia therapy
    Liu, Jingjing
    Tong, Jiayin
    Yang, Haiping
    BMC CANCER, 2022, 22 (01)
  • [39] Prognostic significance of CD33 marker in multiple myeloma
    Leleu, Xavier
    HEMATOLOGIE, 2006, 12 (05): : 299 - 299
  • [40] Targeting CD33 for acute myeloid leukemia therapy
    Jingjing Liu
    Jiayin Tong
    Haiping Yang
    BMC Cancer, 22
12345